NCT02269215View on ClinicalTrials.gov

Single Increasing Doses of BIII 890 CL in Healthy Young Male Volunteers and in Healthy Elderly Male and Female Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

January 31, 2000

Primary Completion Date

September 30, 2000

Conditions
Healthy
Interventions
DRUG

BIII 890 CL

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY